|
Safety and results of anti-PD1 combined with radiosurgery for the treatment of melanoma brain metastases. |
|
|
Speakers' Bureau - Bristol-Myers Squibb; Roche/Genentech |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Bristol-Myers Squibb; Roche/Genentech |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis; Roche/Genentech |
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Roche/Genentech |
Patents, Royalties, Other Intellectual Property - INSERM transfert |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Novartis; Roche |